Enaiblers is a brand dedicated to improving global health equity by tackling Neglected Tropical Diseases (NTDs). With over 1.5 billion people worldwide affected by NTDs, Enaiblers focuses on empowering underserved communities with affordable and accessible AI-based diagnostics. These communities often reside in remote locations with limited infrastructure and diagnostic resources, making it challenging to access proper healthcare.

Enaiblers offers a holistic, scalable, and cost-efficient solution that supports the scale-up of NTD Monitoring & Evaluation programs. Their evidence-based approach aims to improve access to vulnerable communities, enhance data quality, and reduce the time required to obtain actionable results.

The brand also stays at the forefront of innovation and research. They have developed a prototype optical device for diagnosing soil-transmitted helminth and schistosome infections, and they have acquired AI-based digital pathology technology to further advance diagnostics for NTDs.

Enaiblers' mission is driven by empathy and partnership. They actively collaborate with healthcare systems, like in Kenya, to understand user needs and forge meaningful partnerships for positive change.

Support Enaiblers in their endeavor to empower global health equity and make a difference in the lives of those affected by NTDs.